These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1634 related items for PubMed ID: 30585019
1. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Wang Y, Yu M, Yang JX, Cao DY, Zhang Y, Shen K, You Y. Zhonghua Fu Chan Ke Za Zhi; 2018 Dec 25; 53(12):816-822. PubMed ID: 30585019 [Abstract] [Full Text] [Related]
3. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer. Weinberg LE, Kunos CA, Zanotti KM. Int J Gynecol Cancer; 2013 Oct 25; 23(8):1438-45. PubMed ID: 24257558 [Abstract] [Full Text] [Related]
4. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. Veade AE, Foote J, Ehrisman J, Broadwater G, Davidson BA, Lee PS, Secord AA, Berchuck A, Havrilesky LJ. World J Surg Oncol; 2019 May 10; 17(1):80. PubMed ID: 31077193 [Abstract] [Full Text] [Related]
5. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus. Sahin H, Meydanli MM, Sari ME, Kocaman E, Cuylan ZF, Yalcin I, Coban G, Özen Ö, Sirvan L, Güngör T, Ayhan A. Taiwan J Obstet Gynecol; 2019 Jan 10; 58(1):82-89. PubMed ID: 30638487 [Abstract] [Full Text] [Related]
7. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK, Zhang HT, Sun YC, Wu LY. Zhonghua Zhong Liu Za Zhi; 2008 Sep 10; 30(9):690-4. PubMed ID: 19173912 [Abstract] [Full Text] [Related]
8. Clinicopathological Characteristics and Prognostic Factors of Synchronous Endometrial and Ovarian Cancers-A Single-Institute Review of 43 Cases. Jain V, Sekhon R, Pasricha S, Giri S, Modi KB, Shrestha E, Ram D, Rawal S. Int J Gynecol Cancer; 2017 Jun 10; 27(5):938-946. PubMed ID: 28498249 [Abstract] [Full Text] [Related]
11. Synchronous dual primary ovarian and endometrial carcinomas. Pearl ML, Johnston CM, Frank TS, Roberts JA. Int J Gynaecol Obstet; 1993 Dec 10; 43(3):305-12. PubMed ID: 7907042 [Abstract] [Full Text] [Related]
14. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer. Matsuo K, Machida H, Frimer M, Marcus JZ, Pejovic T, Roman LD, Wright JD. Gynecol Oncol; 2017 Dec 10; 147(3):558-564. PubMed ID: 28986093 [Abstract] [Full Text] [Related]
15. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL. Gynecol Oncol; 2000 Apr 10; 77(1):55-65. PubMed ID: 10739691 [Abstract] [Full Text] [Related]
16. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma. Panggid K, Cheewakriangkrai C, Khunamornpong S, Siriaunkgul S. J Obstet Gynaecol Res; 2010 Oct 10; 36(5):1044-8. PubMed ID: 21058438 [Abstract] [Full Text] [Related]
17. Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis. Pecorino B, Laganà AS, Chiantera V, Ferrara M, Di Stefano AB, Di Donna MC, Sorrentino F, Nappi L, Mikuš M, Scollo P. Medicina (Kaunas); 2022 Nov 23; 58(12):. PubMed ID: 36556908 [Abstract] [Full Text] [Related]
18. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer. Cusano E, Myers V, Samant R, Sudai T, Keller A, Le T, E C, Grimes S, Xu Y. Int J Gynecol Cancer; 2018 Jun 23; 28(5):890-894. PubMed ID: 29538248 [Abstract] [Full Text] [Related]